Research and development of photodynamic therapy photosensitizers in China-Reference-Cited by-同舟云学术

Research and development of photodynamic therapy photosensitizers in China

Published:2007-03 Issue:1 Volume:4 Page:13-25
ISSN:1572-1000
Container-title:Photodiagnosis and Photodynamic Therapy
language:en
Short-container-title:Photodiagnosis and Photodynamic Therapy

Author:

Xu De-Yu

Publisher

Elsevier BV

Subject

Pharmacology (medical),Dermatology,Oncology,Biophysics

Reference64 articles.

1. Photoradiation therapy for treatment of malignant tumors;Dougherty;Cancer Res,1978

2. Beijing Institute of Pharmaceutical Industry: Aibulin (Hematoporphyrin). Supplement of Beijing Pharmaceutical Industry; 1983. p. 3–32, 40–63 [in Chinese].

3. Studies on the porphyrin photosensitive drug YHpD;Liu;Acta Pharm Sin,1985

4. Chromatographic analysis of hematoporphyrin derivative and its active components;Liu;Acta Pharm Sin,1984

5. Separation and identification of hematoporphyrin derivative;Liu;Acta Pharm Sin,1984

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in photodynamic therapy of pathologic scar;Photodiagnosis and Photodynamic Therapy;2024-04

2. Current clinical evidence is insufficient to support HMME–PDT as the first choice of treatment for young children with port wine birthmarks;Lasers in Surgery and Medicine;2024-03-20

3. Innovative Design Strategies Advance Biomedical Applications of Phthalocyanines;Advanced Healthcare Materials;2023-05-16

4. The bromoporphyrins as promising anti-tumor photosensitizers in vitro;Photochemical & Photobiological Sciences;2022-11-07

5. Porous organic polymer overcomes the post-treatment phototoxicity of photodynamic agents and maintains their antitumor efficiency;Acta Biomaterialia;2022-09